As of November 2024, Kangmei Pharmaceutical has a market cap of $3.33B. This makes Kangmei Pharmaceutical the world's 3710th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.64B | 0.00% |
2023 | $3.64B | -15.45% |
2022 | $4.31B | -28.80% |
2021 | $6.05B | 15.30% |
2020 | $5.25B | -28.15% |
2019 | $7.30B | -59.50% |
2018 | $18.03B | -58.81% |
2017 | $43.78B | 25.27% |
2016 | $34.95B | 5.31% |
2015 | $33.19B | 115.65% |
2014 | $15.39B | -12.67% |
2013 | $17.62B | 36.99% |
2012 | $12.86B | - |